Llistar Títols per Autor "Martin Castillo, Begoña"

S'han trobat 29 ítems

Llistant ítems des de 0 a 25:

  1  2   
FormatDataTítolAutor
FormatDataTítolAutor
doc icon DUGiDocs 2017 BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells Cuyàs, Elisabet ; Corominas Faja, Bruna ; Muñoz-San Martín, María ; Martin Castillo, Begoña ; Lupu, Ruth ; Brunet i Vidal, Joan ; Bosch Barrera, Joaquim ; Menéndez Menéndez, Javier Abel
out url icon Recercat BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells Cuyàs, Elisabet ; Corominas Faja, Bruna ; Muñoz-San Martín, María ; Martin Castillo, Begoña ; Lupu, Ruth ; Brunet i Vidal, Joan ; Bosch Barrera, Joaquim ; Menéndez Menéndez, Javier Abel
out url icon Recercat BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells Cuyàs, Elisabet ; Corominas Faja, Bruna ; Muñoz-San Martín, María ; Martin Castillo, Begoña ; Lupu, Ruth ; Brunet i Vidal, Joan ; Bosch Barrera, Joaquim ; Menéndez Menéndez, Javier Abel
out url icon Recercat 5 juny 2018 BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells Cuyàs, Elisabet ; Corominas Faja, Bruna ; Muñoz-San Martín, María ; Martin Castillo, Begoña ; Lupu, Ruth ; Brunet i Vidal, Joan ; Bosch Barrera, Joaquim ; Menéndez Menéndez, Javier Abel
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat 5 juny 2018 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2011 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz Duran, Maria Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs abril 2012 Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat 5 juny 2018 Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2014 Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment Menéndez Menéndez, Javier Abel ; Quirantes Piné, Rosa ; Rodríguez Gallego, Esther ; Cufí González, Sílvia ; Corominas Faja, Bruna ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Segura Carretero, Antonio ; Joven, Jorge
out url icon Recercat Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment Menéndez Menéndez, Javier Abel ; Quirantes Piné, Rosa ; Rodríguez Gallego, Esther ; Cufí González, Sílvia ; Corominas Faja, Bruna ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Segura Carretero, Antonio ; Joven, Jorge
out url icon Recercat Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment Menéndez Menéndez, Javier Abel ; Quirantes Piné, Rosa ; Rodríguez Gallego, Esther ; Cufí González, Sílvia ; Corominas Faja, Bruna ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Segura Carretero, Antonio ; Joven, Jorge
out url icon Recercat 5 juny 2018 Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment Menéndez Menéndez, Javier Abel ; Quirantes Piné, Rosa ; Rodríguez Gallego, Esther ; Cufí González, Sílvia ; Corominas Faja, Bruna ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Segura Carretero, Antonio ; Joven, Jorge
out url icon Recercat Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
out url icon Recercat Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
out url icon Recercat 5 juny 2018 Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 20 maig 2015 Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
out url icon Recercat 15 febrer 2020 Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 12 setembre 2016 Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
out url icon Recercat Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
out url icon Recercat Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
out url icon Recercat 5 juny 2018 Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
  1  2   

Matèries

Autors